Feature | November 20, 2012

Societies Issue First Comprehensive Consensus Statement on Troponin Testing

Full clinical situation should be considered when ordering, interpreting test

November 20, 2012 — The American College of Cardiology (ACC), in collaboration with several other professional societies, has released the first comprehensive consensus document outlining clinical considerations for ordering and interpreting tests for troponin, a protein that indicates injury to the heart muscle.

Measuring troponin has been a valuable means to help evaluate patients with suspected heart attack (myocardial infarction) for nearly two decades. Although a positive troponin test is an accurate indicator of injury to the heart muscle, it is not specific to heart attack and may be a red flag for other illnesses or problems.

“We need to be thinking about why we are ordering the troponin test before we order it,” said Kristin Newby, M.D., MHS, of Duke University Medical Center and co-chair of the writing committee for the ACCF 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations. “We hope this document provides a road map to help clinicians be more deliberate when ordering these tests and interpreting the results.”

Troponin helps the heart muscle contract. When the heart muscle is damaged by a heart attack or other illness, the cells die and release troponin into the bloodstream. Troponin levels can remain high for one to two weeks after a heart attack, making it especially useful along with an electrocardiogram (ECG/EKG) and other cardiac biomarkers such as CK-MB.

Even though an elevated troponin level signifies damage to the heart muscle, it does not in and of itself tell clinicians what might have caused the injury. Since troponin testing was first introduced in the early 1990s, it has predominantly been used and defined in the context of diagnosing or ruling out heart attack; but heart failure, surgery, trauma, kidney disease and pulmonary embolism are among other conditions that can lead to elevated troponin levels.

“There are many things that can cause damage to the heart muscle that would allow troponin to leak in the circulation where we can measure it, and it’s not always due to heart attack,” Newby said. “So if we are indiscriminate in how we order these tests or we aren’t paying attention to the clinical scenario before us, we may miss something important.”

Another key point emphasized in the report is that regardless of why someone has a positive troponin result, it is highly associated with worse outcomes and, therefore, needs to be looked into further.

“If you have a pulmonary embolism or end-stage renal disease and your troponin is elevated, your prognosis – how you are expected to do – is worse,” said Newby. “Just as if you have a heart attack and your troponin is positive, your prognosis is likely worse than in someone with unstable angina whose troponin [level] is not elevated.”

In this way, elevated troponin levels can also be used to help guide treatment and gauge patient appropriateness for more aggressive therapy. “It is incumbent on all practitioners to fully understand the implications of an elevated troponin level in a given patient in order to initiate the appropriate treatment and to optimize outcomes,” the document states.

Still, Newby cautions that troponin levels should not be used in isolation or as a routine screening test in the emergency department or other settings. “It’s a great marker, it does exactly what it is supposed to do, but how we interpret the results has to consider the clinical context in which the test was ordered,” said Newby, adding that careful attention will allow for optimal interpretation, diagnosis, risk stratification and patient management.

In addition to providing a review of the most recent research on troponin testing and its clinical applications, the document also provides useful at-a-glance resources including:

  • Frequently asked questions regarding the use of troponin in the clinical setting – what an elevated troponin level means, when the test should be ordered and prognosis;
  • A schematic of potential reasons for elevated troponin levels; and
  • Flow diagrams to help clinicians determine when to use troponin in therapeutic decision-making.


This document was developed in collaboration with the American Association for Clinical Chemistry, American College of Chest Physicians, American College of Emergency Physicians, American Heart Association (AHA), and Society for Cardiovascular Angiography and Interventions (SCAI). The writing committee represents a broad spectrum of clinicians who typically use troponin testing, including those from emergency and family medicine to cardiologists. As troponin tests become more sensitive, experts say conditions that result in smaller spikes in troponin will be identified.

The full report will be published in the Dec. 12, 2012, issue of the Journal of the American College of Cardiology and will be accessible on the ACC website.

For more information: www.cardiosource.org/acc

Related Content

AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patient
News | Blood Testing | September 04, 2018
Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses peripheral artery disease (PAD)...
More Sensitive Blood Test Diagnoses Heart Attacks Faster
News | Blood Testing | August 06, 2018
August 6, 2018 — A new test to assess a whether or not someone is having a...
Singulex cTnl Assay Can Identify Presence, Severity of CAD in Stable, Symptomatic Outpatients
News | Blood Testing | March 26, 2018
March 26, 2018 — Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singule
Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing | September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Patients With Low Corus CAD Test Score Less Likely to Undergo Cardiac Referra
News | Blood Testing | May 02, 2017
CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET Registry in...
New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors
News | Blood Testing | April 28, 2017
Prevencio Inc. announced the publication of data demonstrating that a simple new blood test is more accurate than...
New Study Pursues Universal Sample Bank for Troponin Tests
News | Blood Testing | April 13, 2017
April 13, 2017 — A study published recently in the American Association for Clinical Chemistry’s (AACC)...
PTS Diagnostics, FDA 510k clearance, extended HDL range, lipid panel test strips
News | Blood Testing | April 05, 2017
PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded top range for...
heart attack evaluation, blood test, HEART Score, ER, emergency room, Circulation Cardiovascular Quality and Outcomes study
News | Blood Testing | March 01, 2017
Up to 40 percent of emergency room (ER) patients with chest pain can safely go home in a little under 2 hours, using a...
troponin blood test, heart disease risk, heart attack, British Heart Foundation, BHF
News | Blood Testing | January 04, 2017
A high-sensitivity blood test could be used to predict which patients are at risk of a heart attack according to new...
Overlay Init